EphA3 antibodies for the treatment of solid tumors
US8637016B2 · kind B2 · utility
0Cited by
4References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 10, 2008 |
| Grant date | Jan 28, 2014 |
| Priority date | — |
| Expiry date | Sep 4, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and compositions comprising anti-EphA3 antibodies for the treatment of solid tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.